CD8A and neoplasm: Tumor Metrics: Colon and breast cancer models showed a substantial reduction in tumor growth following vaccination with T. cruzi epimastigote lysates.Immunological Response: Both CD4+ and CD8+ T cells were activated in immunized rats, and their spleens responded more cytotoxically to tumors than did the controls.